Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Niraparib 则乐 尼拉帕利

Niraparib (trade name in Hong Kong: Zele) is a highly effective and selective once-daily oral small molecule poly(ADP-ribose) PARP1/2 inhibitor for late-stage recurrent ovarian cancer. Maintenance therapy can significantly extend the survival period of patients with advanced ovarian cancer and reduce the recurrence of ovarian cancer.


Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.